Modern Diagnostic and Research Centre share price: Stock lists at over 10% premium on BSE SME; here's how much investors made

Modern Diagnostic share price: Shares of Modern Diagnostic and Research Centre made a decent debut on the BSE SME platform on Wednesday, January 7, 2026.

The stock listed at ₹99.5 per unit, reflecting a premium of 10.56% over the IPO issue price of ₹90 per unit.

Modern Diagnostic share price: Here's how much investors made per lot

The initial public offering got subscribed a whopping 350.49 times, as investors placed bids for 1,02,95,90,400 shares compared to 29,37,600 shares on offer, according to the BSE data.

The quota reserved for qualified institutional buyers (QIBs) was subscribed 193.51 times, while the non-institutional investors (NIIs) part was booked 519.38 times. The individual investors' portion saw 342.46 times subscription.

The ₹36.89 crore initial share sale was a fresh issuance of 40.99 lakh shares aggregating to ₹36.89 crore, with no offer for sale (OFS) component.

The money generated will be utilised for repayment of debt, working capital requirements, purchase of medical equipment for diagnostic centres and laboratories and corporate general purposes.

Dr Devendra Singh Yadav, the company's Chairman and Managing Director, said, "The listing of the company’s equity shares is a significant milestone for the company as it undertakes its next phase of expansion...The proposed IPO will provide us with the financial strength to accelerate our expansion strategy."

Before the IPO, the company mobilised ₹10.45 crore from nine anchor investors, including SB Opportunities Fund II, Aarth AIF Growth Fund, 360 One Prime Ltd, Ekamya Pragati Scheme-I, Sunrise Investment Trust-Sunrise Investment Opportunities Fund and Vijit Growth Fund, among others.

Modern Diagnostic and Research Centre is involved in offering domestic diagnostic and related healthcare test services. It provides a single-stop solution for radiology and pathology testing services.